Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.

Humaida, Sara et al.·Cureus·2025·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.
Published In:: Cureus, 17(5), e85123 (2025)
Authors:: Humaida, Sara, Manzalji, Kamar, Seyam, Naheel, Al-Masalmani, Lolwa
Database ID:: RPEP-11480

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-11480·https://rethinkpeptides.com/research/RPEP-11480

APA

Humaida, Sara; Manzalji, Kamar; Seyam, Naheel; Al-Masalmani, Lolwa. (2025). Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.. Cureus, 17(5), e85123. https://doi.org/10.7759/cureus.85123

MLA

Humaida, Sara, et al. "Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.." Cureus, 2025. https://doi.org/10.7759/cureus.85123

RethinkPeptides

RethinkPeptides Research Database. "Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent I..." RPEP-11480. Retrieved from https://rethinkpeptides.com/research/humaida-2025-dual-glucagonlike-peptide1-glp1

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database